StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Post by Bully88on Jul 09, 2020 11:04am

79 Views

Post# 31245215

The only number we need

The only numbers we need are,

1. total tests completed so far
2. Daily tests completed (average)

After that we will know where we stand.

They have stated their goal of 1000+ tests a day
they have stated 250,000 test order received.

all meaning they forseee MILLIONS in revenue in the short term

once we establish we are testing at a rate above 100 a day we are absolutely printing money

Bullboard Posts

Cannara reports record growth and profitability in Q4 2023